000 | 01174 a2200313 4500 | ||
---|---|---|---|
005 | 20250517065828.0 | ||
264 | 0 | _c20161216 | |
008 | 201612s 0 0 eng d | ||
022 | _a1876-4479 | ||
024 | 7 |
_a10.1093/ecco-jcc/jjv222 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGenua, Marco | |
245 | 0 | 0 |
_aAnti-TNF Antibodies and Autophagy: A Hidden Nexus for a Successful Therapeutic Response? _h[electronic resource] |
260 |
_bJournal of Crohn's & colitis _cMar 2016 |
||
300 |
_a237-8 p. _bdigital |
||
500 | _aPublication Type: Editorial | ||
650 | 0 | 4 |
_aAnti-Inflammatory Agents _xpharmacology |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xpharmacology |
650 | 0 | 4 |
_aAutophagy _xdrug effects |
650 | 0 | 4 | _aGenetic Predisposition to Disease |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInflammatory Bowel Diseases _xdrug therapy |
650 | 0 | 4 | _aPrecision Medicine |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
700 | 1 | _aBecker, Christoph | |
700 | 1 | _aVetrano, Stefania | |
773 | 0 |
_tJournal of Crohn's & colitis _gvol. 10 _gno. 3 _gp. 237-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/ecco-jcc/jjv222 _zAvailable from publisher's website |
999 |
_c25521880 _d25521880 |